Status:

COMPLETED

Ultrasound-guided Percutaneous Neuromodulation Versus Dry Needling in Shoulder Pain Treatment

Lead Sponsor:

University of Alcala

Conditions:

Shoulder Pain

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Background: nonspecific shoulder pain is very common and the symptoms can persist for 6 to 12 months in half of patients. Ultrasound-guided Percutaneous Neuromodulation (US-guided PNM) is an intervent...

Detailed Description

Shoulder pain is the third reason for medical consultation in the world. Many treatment techniques have been proposed. Neuromodulation techniques through the application of an analgesic electric curre...

Eligibility Criteria

Inclusion

  • Chronic mechanical unilateral shoulder pain of non-specific origin of at least 3 months of evolution
  • Weakness in the abduction force and / or external rotation of the shoulder.

Exclusion

  • Previous shoulder surgery.
  • Previous history of shoulder dislocation
  • Whiplash.
  • Cervical radiculopathy.
  • Total rupture of the rotator cuff.
  • Adhesive capsulitis.
  • Fibromyalgia diagnosis.
  • Diabetes.
  • Needle phobia or some contraindication for dry needling (anticoagulants or psychiatric disorders).
  • Bilateral shoulder pain.
  • Pregnancy or having received a dry puncture in the shoulder region in the last 6 months

Key Trial Info

Start Date :

September 5 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 31 2024

Estimated Enrollment :

62 Patients enrolled

Trial Details

Trial ID

NCT04454671

Start Date

September 5 2020

End Date

May 31 2024

Last Update

June 3 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Institut Physiotherapy AND pain

Alcalá de Henares, Madrid, Spain, 28805

2

Overall Study Officials

Alcalá de Henares, Madrid, Spain, 28807